REVIEW
Published on 16 Jul 2024
Liver cirrhosis: current status and treatment options using western or traditional Chinese medicine
doi 10.3389/fphar.2024.1381476
- 3,995 views
- Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
- Research Topics
- Methods in Gastrointestinal and Hepatic Pharmacology 2023
Methods in Gastrointestinal and Hepatic Pharmacology 2023
4,943
Total downloads
19k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 28 Jun 2024
A novel bioinformatics strategy to uncover the active ingredients and molecular mechanisms of Bai Shao in the treatment of non-alcoholic fatty liver disease
doi 10.3389/fphar.2024.1406188
- 777 views
ORIGINAL RESEARCH
Published on 05 Jun 2024
Quantitative evaluation of the time-course and efficacy of targeted agents for ulcerative colitis
doi 10.3389/fphar.2024.1399963
- 886 views
ORIGINAL RESEARCH
Published on 01 May 2024
Phytic acid attenuates acetaminophen-induced hepatotoxicity via modulating iron-mediated oxidative stress and SIRT-1 expression in mice
doi 10.3389/fphar.2024.1384834
- 1,307 views
ORIGINAL RESEARCH
Published on 01 May 2024
Investigating the L-Glu-NMDA receptor-H2S-NMDA receptor pathway that regulates gastric function in rats’ nucleus ambiguus
doi 10.3389/fphar.2024.1389873
- 644 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Apr 2024
Propranolol can correct prolonged QT intervals in patients with cirrhosis
doi 10.3389/fphar.2024.1370261
- 1,528 views
BRIEF RESEARCH REPORT
Published on 27 Mar 2024
Antifungal effects of echinocandins diminish when exposed to intestinal lumen contents: a finding with potentially significant clinical implications
doi 10.3389/fphar.2024.1376656
- 600 views
REVIEW
Published on 29 Feb 2024
Nobiletin from citrus peel: a promising therapeutic agent for liver disease-pharmacological characteristics, mechanisms, and potential applications
doi 10.3389/fphar.2024.1354809
- 4,321 views
- 6 citations
ORIGINAL RESEARCH
Published on 23 Feb 2024
Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma
doi 10.3389/fphar.2024.1364924
- 1,332 views
Published in
Frontiers in Pharmacology
- Gastrointestinal and Hepatic Pharmacology
Impact
- 19kTopic views
- 13kArticle views
- 4,943Article downloads